Identification of deregulation in protein expression level of erlotinib-resistant H1299 cell lines
Erlotinib, a small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, has been shown to be an effective solution in treating non-small cell lung cancer (NSCLC). However, most patients who initially show a good response to erlotinib treatment eventually develop resistant and...
| Auteur principal: | |
|---|---|
| Format: | Project Paper Report |
| Langue: | English |
| Publié: |
2015
|
| Accès en ligne: | http://psasir.upm.edu.my/id/eprint/91013/1/FBSB%202015%20132%20-%20IR.pdf |